Genpact Ltd. (G) intrinsic value & 10-year financials

Genpact Ltd. (G) has a Graham intrinsic value of $66.16 per share. At $37.26 on Oct 17, 2026, the stock trades 44% below that value. Over the last 10 fiscal years revenue grew 7.9% a year to $5.1B, with an average return on invested capital of 15.4%.

Graham intrinsic value
$66.16
Share price (Oct 17, 2026)
$37.26
Price vs Graham value
44% below
Market cap
$6.6B
Revenue (FY2025)
$5.1B
Revenue growth (10-yr CAGR)
7.9%
ROIC (10-yr avg)
15.4%
Free cash flow (FY2025)
$734.7M

G 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $5.1B $552.5M $3.13 $734.7M 14.8% 17.4%
FY2024 $4.8B $513.7M $2.85 $532.7M 14.7% 17.1%
FY2023 $4.5B $631.3M $3.41 $435.4M 14.1% 21.9%
FY2022 $4.4B $353.4M $1.88 $393.1M 11.5% 13.7%
FY2021 $4.0B $369.4M $1.91 $640.9M 12.7% 13.6%
FY2020 $3.7B $308.3M $1.57 $514.1M 11.8% 11.8%
FY2019 $3.5B $304.9M $1.56 $353.0M 12.2% 13.2%
FY2018 $3.0B $282.0M $1.45 $254.5M 11.6% 13.5%
FY2017 $2.7B $263.1M $1.34 $301.8M 12.0% 15.0%
FY2016 $2.6B $269.7M $1.28 $257.0M 13.3% 17.3%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Genpact LTD has demonstrated mature, steady growth, with revenue compounding at 7.9% annually over the past decade.

Genpact LTD has earned high returns on invested capital, averaging 15.5% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.

Over the decade, Genpact LTD shows that management has aggressively returned capital to shareholders by retiring 15.9% of outstanding shares, and that the company has leveraged its balance sheet to sustain operations.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Genpact LTD is modeled at 8.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $66.16 per share.

G stock: frequently asked questions

What is the intrinsic value of Genpact Ltd. (G) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 8.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, G's intrinsic value is about $66.16 per share.

Is G stock undervalued?

At $37.26 (close on Oct 17, 2026), G trades 44% below its Graham value of $66.16. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

How fast has Genpact Ltd. grown?

Revenue went from $2.6B in fiscal 2016 to $5.1B in fiscal 2025, a compound annual growth rate of 7.9%. Net income was $552.5M in fiscal 2025.

Does Genpact Ltd. generate free cash flow?

Genpact Ltd. generated $734.7M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 10 of the last 10 reported years.

What is G's return on invested capital?

Average ROIC over the last 10 fiscal years was 15.4%, and average return on equity was 21.2%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this G data come from?

From Genpact Ltd.'s annual 10-K filings on SEC EDGAR, most recently filed Aug 7, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar management consulting services stocks